Literature DB >> 26494714

Disseminated cryptococcosis in an apparently immunocompetent patient presenting with primary intraventricular haemorrhage.

Partha Pal1, Sayantan Ray2, Sisir Kumar Patra3, Debabrata Mukherjee1.   

Abstract

Disseminated cryptococcosis is uncommon and almost always occurs in HIV-infected patients. However, cryptococcosis can also be found in patients of organ transplantation, in those on disease modifying agents for rheumatological conditions and in patients with underlying immunodeficiency. Cryptococcal infection may occur in an immunocompetent patient, but the pathogenic strain is usually Cryptococcus gattii, and not C. neoformans. However, disseminated disease, especially cerebral involvement in the form of primary intraventricular haemorrhage, is exceedingly rare. We report a case of disseminated cryptococcosis with cutaneous, cerebral and bone marrow involvement in an HIV-negative, apparently immunocompetent patient. Although the patient did not have the usual immunocompromising diseases, there were clinical signs possibly indicating a weakened immune system. This report highlights the need for awareness of disseminated cryptococcosis among patients with no apparent immunocompromising conditions. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26494714      PMCID: PMC4620221          DOI: 10.1136/bcr-2015-210250

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

Review 1.  Cryptococcosis.

Authors:  Methee Chayakulkeeree; John R Perfect
Journal:  Infect Dis Clin North Am       Date:  2006-09       Impact factor: 5.982

2.  Images in clinical medicine. Disseminated cryptococcosis.

Authors:  Guillaume Martin-Blondel; Loic Ysebaert
Journal:  N Engl J Med       Date:  2014-05-01       Impact factor: 91.245

Review 3.  Do major species concepts support one, two or more species within Cryptococcus neoformans?

Authors:  Kyung J Kwon-Chung; Ashok Varma
Journal:  FEMS Yeast Res       Date:  2006-06       Impact factor: 2.796

4.  Mycotic aneurysm and cerebral infarction resulting from fungal sinusitis: imaging and pathologic correlation.

Authors:  R W Hurst; A Judkins; W Bolger; A Chu; L A Loevner
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

5.  Differentiation of Cryptococcus neoformans varieties and Cryptococcus gattii using CAP59-based loop-mediated isothermal DNA amplification.

Authors:  S Lucas; M da Luz Martins; O Flores; W Meyer; I Spencer-Martins; J Inácio
Journal:  Clin Microbiol Infect       Date:  2009-08-20       Impact factor: 8.067

Review 6.  Fungal infections of the central nervous system: the clinical syndromes.

Authors:  J M K Murthy
Journal:  Neurol India       Date:  2007 Jul-Sep       Impact factor: 2.117

7.  Cryptococcal sepsis diagnosed by bone marrow examination.

Authors:  Omar A Abdul-Rahman; Hannah Gay; Elizabeth Caldwell; Gail C Megason
Journal:  J Pediatr Hematol Oncol       Date:  2004-08       Impact factor: 1.289

8.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

9.  Demonstration of Cryptococcus neoformans in a stained bone marrow specimen.

Authors:  F Robert; J R Durant; R A Gams
Journal:  Arch Intern Med       Date:  1977-05

10.  Clinical and mycological profile of cryptococcosis in a tertiary care hospital.

Authors:  M R Capoor; D Nair; M Deb; B Gupta; P Aggarwal
Journal:  Indian J Med Microbiol       Date:  2007-10       Impact factor: 0.985

View more
  1 in total

1.  Drug development for cryptococcosis treatment: what can patents tell us?

Authors:  Juliana Santos-Gandelman; Alice Machado-Silva
Journal:  Mem Inst Oswaldo Cruz       Date:  2019-01-31       Impact factor: 2.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.